“Crisis-Capable Compliance: The CCO at the Crossroads of AI, Ethics, and Leadership”

April 2026

Abstract

The role of the Chief Compliance Officer is undergoing a fundamental transformation in the era of artificial intelligence. No longer confined to oversight and enforcement, the CCO is emerging as a strategic leader at the intersection of technology, ethics, and business judgment. As organizations deploy AI at scale, compliance is no longer reactive—it becomes predictive, embedded, and inseparable from innovation itself. For leaders shaped by environments where uncertainty is constant, such as Argentina, emotional intelligence and intuition are not soft skills, they are survival tools. They sharpen judgment, enable faster pattern recognition, and allow leaders to navigate ambiguity with clarity. In the AI era, these human capabilities become a competitive advantage. While algorithms process data, the CCO must interpret intent, assess risk in context, and ensure decisions align not only with regulations, but with values.

Authors

Dolores Guzman

Legal & Compliance Director , Apex America , UK

Graduated with a Master's degree in Business Law from the Universidad Austral and Certified in Compliance by IAE, UCEMA (Universidad del Cema) and IFCA (International Federation of Compliance Association). She is a Professor of Corporate Law at the Faculty of Law of the Universidad Nacional de Córdoba and a lecturer for postgraduate courses at UNC, ICDA, and other renowned universities. She is the Corporate Legal and Compliance Director at Grupo Apex America, a multinational BPO services corporation, founded in Argentina, with eleven thousand employees. In her role as a member of Apex America´s Ethics Committee and Compliance Officer, she has designed and implemented the Company's integrity programme, aiming to generate continuous training and adherence to organisational ethical values and principles. Prior to this, she worked as an Associate in well-established law firms in the city of Córdoba, including Capdevila & Palazzo Abogados and Viramonte & Acuña Abogados. From an institutional perspective, she is a member of the Advisory Council of the American Chamber of Commerce (AmCham) Córdoba Delegation and co-director of its Legal and Fiscal Affairs Committee.

Fabiana Lacerca-Allen

Chief Compliance Officer, Cipla, USA

M. Fabiana Lacerca-Allen is a senior compliance and legal executive with over 30 years of experience leading global compliance, legal, and governance programs across the pharmaceutical, biotechnology, and technology sectors. She currently serves as Chief Compliance Officer for Cipla USA and has held senior leadership roles at Aimmune Therapeutics, Elan Pharmaceuticals, Mylan, Bristol-Myers Squibb, Microsoft, Merck, and AT&T. She brings deep expertise in risk-based compliance program design aligned with DOJ and OIG expectations, including third-party risk management, global investigations, data integrity, ethical culture transformation, and crisis preparedness. She regularly advises boards and executive leadership teams on international operations and enterprise governance. Fabiana serves as a Board Director and Audit Committee Member of Shield Therapeutics and holds a risk and governance advisory position with the International Federation of Red Cross and Red Crescent Societies (IFRC). She is also Adjunct Professor at Fordham University School of Law, teaching compliance, ethics, and governance. She is author of Crisis Capable and a frequent international speaker. She previously served as Chair of the Bay Area Ethics & Compliance Association and Co-Chair for CBI (Advanstar). She holds a JD and LLM and conducted academic research in international environmental law through the Gioja Research Institute.

Companies

Apex America

Apex America is a leading BPO and Customer Experience company in Latin America, founded in 2003 by Argentinian entrepreneurs. With over 20 years of experience and more than 11,000 employees across seven countries, the company has been incorporated into Vensure group, positioning itself as a trusted strategic partner. Apex America has developed a technological hub of excellence aimed at unlocking the human and professional potential of its teams, placing people at the core of its operations. The company delivers innovative solutions in customer experience management, designing, implementing, and managing end-to-end services to ensure high-quality interactions across multiple customer service channels. By focusing on understanding customer needs and making every interaction meaningful, Apex America helps enhance brand loyalty and drive revenue growth for the organizations it serves.

Cipla

Cipla Limited is a leading Indian multinational pharmaceutical company, founded in 1935, focused on developing high-quality, affordable medicines across various therapeutic areas, including respiratory, cardiovascular, and HIV/AIDS. With 46 global manufacturing sites, it produces 1,500+ products and operates in 80+ countries.

Multinational organizations increasingly operate in jurisdictions where the rule of law is weak, inconsistently enforced, or subject to political and economic influence. For pharmaceutical and biotechnology companies, these environments present...Read more

Fabiana Lacerca-Allen

Chief Compliance Officer, Cipla, USA

Valentina Lacerca-Allen

Title Marketing/ Communication Specialist, Ethiprax LLC., USA

A Path Through the Forest - The Role of Agency Guidance in Developing Regulatory Compliance Programs

Counsel involved in developing regulatory compliance programs know that merely looking at the statute and regulations is not enough. They need to look to multiple sources of information to determine...Read more

Jack Sorokin

Adjunct Instructor, Fremont College, USA

The Impact of the Fraud and Abuse Laws on Pharmaceutical Advertising and Marketing Compliance: A Manufacturer's Perspective

The intersection between the health care fraud and abuse laws and pharmaceutical marketing practices in the U.S. raises interesting compliance issues for pharmaceutical manufacturers, particularly in light of the newly...Read more

Leslie Restaino

General Counsel, Validus Pharmaceuticals, USA

Corporate Compliance in a Fragmented Regulatory Landscape

As multinational companies expand into diverse and rapidly evolving markets, legal and compliance teams face increasing pressure to navigate fragmented regulatory frameworks while upholding consistent global standards. This paper draws...Read more

Moutaz Abdullat

General Counsel, Fererro , UAE